About Omeros (OMER)
Omeros Corporation is a commercial-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, c... Read more
- USD3.18
- USD3.31
- USD3.10
- USD7.80
- -9.00%
- --
- 197.44k
- 389.92k
- 183M
- 0.92
- -43.60%
Stock News
3 hours ago
Sumitomo Corporation, Sumitomo Mitsui Finance and Leasing Co., Ltd. (SMFL) and Gogoro Inc. to Explore First of its Kind Partnership to Accelerate Gogoro's Global Business Expansion
Yahoo
3 hours ago
Cementos Pacasmayo S.A.A. Announces Consolidated Results for First Quarter 2024
Yahoo
3 hours ago
Taiwan Stocks See $5 Billion Outflows as AI Hype Takes Breather
Yahoo
4 hours ago
Forget Nvidia: 2 Artificial Intelligence (AI) Stocks to Buy Instead
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
